The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
Mesenchymal stromal cells (MSCs) are known to have immunosuppressive ability and have been used in clinical treatment of acute graft-versus-host disease, one of severe complications of the hematopoietic stem cell transplantation. However, MSCs are activated to suppress the immune system only after e...
Main Authors: | Haiping He, Atsuko Takahashi, Takeo Mukai, Akiko Hori, Miwako Narita, Arinobu Tojo, Tonghua Yang, Tokiko Nagamura-Inoue |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.686356/full |
Similar Items
-
Umbilical Cord-Derived Mesenchymal Stromal Cells Contribute to Neuroprotection in Neonatal Cortical Neurons Damaged by Oxygen-Glucose Deprivation
by: Takeo Mukai, et al.
Published: (2018-06-01) -
Mesenchymal Stromal Cells Perspective: New Potential Therapeutic for the Treatment of Neurological Diseases
by: Takeo Mukai, et al.
Published: (2021-07-01) -
Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review
by: Samira Ziaei, et al.
Published: (2016-03-01) -
Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review
by: Kai Yuan, et al.
Published: (2019-12-01) -
Identification of a binding target of triptolide and related studies
by: Zhao, Qian, et al.
Published: (2013)